Growing community of inventors

Shorewood, WI, United States of America

Jeffrey A Medin

Average Co-Inventor Count = 4.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Jeffrey A MedinLawrence G Lum (2 patents)Jeffrey A MedinDaniel H Fowler (2 patents)Jeffrey A MedinRobyn A A Oldham (2 patents)Jeffrey A MedinArchana Thakur (1 patent)Jeffrey A MedinEverett R Tate (1 patent)Jeffrey A MedinRobert Blake Hill (1 patent)Jeffrey A MedinMary L Faber (1 patent)Jeffrey A MedinMurtaza S Nagree (1 patent)Jeffrey A MedinRobyn A Oldham (1 patent)Jeffrey A MedinKaothara Oluwakemi Adeyanju (1 patent)Jeffrey A MedinTania Felizardo (1 patent)Jeffrey A MedinTania Felizardo (1 patent)Jeffrey A MedinMurtaza S Nagree (0 patent)Jeffrey A MedinJeffrey A Medin (5 patents)Lawrence G LumLawrence G Lum (10 patents)Daniel H FowlerDaniel H Fowler (7 patents)Robyn A A OldhamRobyn A A Oldham (4 patents)Archana ThakurArchana Thakur (4 patents)Everett R TateEverett R Tate (2 patents)Robert Blake HillRobert Blake Hill (2 patents)Mary L FaberMary L Faber (2 patents)Murtaza S NagreeMurtaza S Nagree (2 patents)Robyn A OldhamRobyn A Oldham (1 patent)Kaothara Oluwakemi AdeyanjuKaothara Oluwakemi Adeyanju (1 patent)Tania FelizardoTania Felizardo (1 patent)Tania FelizardoTania Felizardo (1 patent)Murtaza S NagreeMurtaza S Nagree (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The Medical College of Wisconsin, Inc. (5 from 181 patents)

2. University of Virginia Patent Foundation (4 from 997 patents)


5 patents:

1. 12391764 - Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD30+ malignancies

2. 12351639 - Anti-CD30 antibodies

3. 12239693 - Use of lentivector-transduced T-Rapa cells for amelioration of lysosomal storage disorders

4. 12076344 - T-Rapa cells as novel effector cell type for chimeric antigen receptor therapy

5. 12006511 - Recombinant PD-L1 peptides and methods of use

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…